Synthesis and structure-activity relationships of TAN-1511 analogues as potent hematopoietic agents. 1998

F Itoh, and Y Nishikimi, and A Hasuoka, and Y Yoshioka, and K Yukishige, and S Tanida, and T Aono
Pharmaceutical Research Laboratories II, Takeda Chemical Industries, Ltd., Osaka, Japan.

A series of TAN-1511 analogues bearing a non-peptide spacer in place of the Gly-Gly-Gly sequence in the peptide moiety was synthesized, and the effects of these compounds on the proliferation of bone marrow cells in culture and experimental leukocytopenia in mice were examined. The structure-activity relationships obtained were as follows. As the substituent at the 2-position of the 4-thiaheptanoic acid framework, an amino group, methyl group or hydrogen was preferable; as a spacer in place of the Gly-Gly-Gly sequence, a 4-aminobenzoyl or 4-aminomethylbenzoyl group was suitable; and as the fatty acids bonded to the 6,7-dihydroxy groups, C16 fatty acid was best. Compounds 12f, 30d and 30i potently promoted the proliferation of bone marrow cells in culture and the restoration of leukocyte counts in a murine leukocytopenia model.

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D001854 Bone Marrow Cells Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells. Bone Marrow Cell,Cell, Bone Marrow,Cells, Bone Marrow,Marrow Cell, Bone,Marrow Cells, Bone
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005227 Fatty Acids Organic, monobasic acids derived from hydrocarbons by the equivalent of oxidation of a methyl group to an alcohol, aldehyde, and then acid. Fatty acids are saturated and unsaturated (FATTY ACIDS, UNSATURATED). (Grant & Hackh's Chemical Dictionary, 5th ed) Aliphatic Acid,Esterified Fatty Acid,Fatty Acid,Fatty Acids, Esterified,Fatty Acids, Saturated,Saturated Fatty Acid,Aliphatic Acids,Acid, Aliphatic,Acid, Esterified Fatty,Acid, Saturated Fatty,Esterified Fatty Acids,Fatty Acid, Esterified,Fatty Acid, Saturated,Saturated Fatty Acids
D005260 Female Females
D006397 Hematinics Agents which improve the quality of the blood, increasing the hemoglobin level and the number of erythrocytes. They are used in the treatment of anemias. Erythropoiesis Stimulating Agent,Hematinic,Hematopoietic Agents,Erythropoiesis Stimulating Agents,Agent, Erythropoiesis Stimulating,Stimulating Agent, Erythropoiesis
D006410 Hematopoiesis The development and formation of various types of BLOOD CELLS. Hematopoiesis can take place in the BONE MARROW (medullary) or outside the bone marrow (HEMATOPOIESIS, EXTRAMEDULLARY). Hematopoiesis, Medullary,Haematopoiesis,Medullary Hematopoiesis

Related Publications

F Itoh, and Y Nishikimi, and A Hasuoka, and Y Yoshioka, and K Yukishige, and S Tanida, and T Aono
July 1995, The Journal of antibiotics,
F Itoh, and Y Nishikimi, and A Hasuoka, and Y Yoshioka, and K Yukishige, and S Tanida, and T Aono
January 2020, ChemMedChem,
F Itoh, and Y Nishikimi, and A Hasuoka, and Y Yoshioka, and K Yukishige, and S Tanida, and T Aono
November 2012, ChemMedChem,
F Itoh, and Y Nishikimi, and A Hasuoka, and Y Yoshioka, and K Yukishige, and S Tanida, and T Aono
September 2004, Bioorganic & medicinal chemistry letters,
F Itoh, and Y Nishikimi, and A Hasuoka, and Y Yoshioka, and K Yukishige, and S Tanida, and T Aono
April 1990, Journal of medicinal chemistry,
F Itoh, and Y Nishikimi, and A Hasuoka, and Y Yoshioka, and K Yukishige, and S Tanida, and T Aono
December 2019, Bioorganic & medicinal chemistry letters,
F Itoh, and Y Nishikimi, and A Hasuoka, and Y Yoshioka, and K Yukishige, and S Tanida, and T Aono
December 1997, Chemical & pharmaceutical bulletin,
F Itoh, and Y Nishikimi, and A Hasuoka, and Y Yoshioka, and K Yukishige, and S Tanida, and T Aono
March 2005, Bioorganic & medicinal chemistry,
F Itoh, and Y Nishikimi, and A Hasuoka, and Y Yoshioka, and K Yukishige, and S Tanida, and T Aono
August 2017, European journal of medicinal chemistry,
F Itoh, and Y Nishikimi, and A Hasuoka, and Y Yoshioka, and K Yukishige, and S Tanida, and T Aono
January 1985, Advances in prostaglandin, thromboxane, and leukotriene research,
Copied contents to your clipboard!